USP Expands Presence in India.
The US Pharmacopeia (USP) opened last week a newly expanded state-of-the-art facility in the IKP Knowledge Park of Hyderabad, India. The facility expands USP’s presence in the area from 14,000 square feet to more than 100,000 square feet. An additional 20 employees, from the base number of 70, will be added throughout the coming year.
Former FDA Commissioner Dr. Charles Edwards has passed away. During his tenure, "Dr. Edwards was one of the country’s most ardent drug safety advocates, ordering the extensive review of over-the-counter drugs for safety, effectiveness, and accuracy in labeling," wrote current Commissioner Margaret Hamburg in a letter on the FDA website. Dr. Edwards led FDA from December 1969 to March 1973, during which time he steered the agency towards a greater regulatory role and helped to double the agency’s budget.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.